Multi-center phase ? clinical trial of Qinxiang Qingjie Oral Liquid for treating pediatric patients of acute upper respiratory infection with syndrome of heat in both exterior and interior

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2200005578

Enrollment

Unknown

Registered

2022-02-01

Start date

2005-05-30

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute upper respiratory infection with the syndrome of heat in both exterior and interior

Interventions

Experimental group :qinxiangqingjiekoufuye

control group:huangzhihuakoufuye

Eligibility

Sex/Gender

All

Age

0.5 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1.Meet the western diagnostic criteria for acute upper respiratory tract infection; 2.Conforming to the standard of syndrome differentiation of both external and internal heat syndromes; 3.The ages ranged from 6 months to 14 years; 4.The course of the disease was less than 48 hours. 5.The parent or guardian signed the informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients with serious primary diseases of heart, brain, liver, kidney and hematopoietic system; 2.Suppurative tonsillitis, bronchitis, bronchiolitis, pneumonia and other diseases; 3.Severe malnutrition, rickets; 4.Persons under 3 years of age with a history of febrile convulsions; 5.Allergic to known components of this preparation; 6.According to the doctor's judgment, easy to cause lost visitors

Design outcomes

Primary

Measure	Time frame
Disease curative effect;he time when the body temperature returns to normal;TCM syndrome changes;	—

Countries

China

Contacts

Public Contactrong Ma

yfyjdb@163.com022(27432721)

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026